<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP09821103B8W1" file="EP09821103W1B8.xml" lang="en" country="EP" doc-number="2349282" kind="B8" correction-code="W1" date-publ="20200226" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCY..TRBGCZEEHUPLSK..HRIS..MTNO....SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 1.7.2 (20 November 2019) -  2999001/0</B007EP></eptags></B000><B100><B110>2349282</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20200226</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>09821103.0</B210><B220><date>20091013</date></B220><B240><B241><date>20110502</date></B241><B242><date>20170127</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>250412</B310><B320><date>20081013</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20200226</date><bnum>202009</bnum></B405><B430><date>20110803</date><bnum>201131</bnum></B430><B450><date>20200115</date><bnum>202003</bnum></B450><B452EP><date>20190805</date></B452EP><B480><date>20200226</date><bnum>202009</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  31/7036      20060101AFI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61P  11/00        20060101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K   9/127       20060101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  47/44        20170101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61P  11/12        20060101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61P  31/04        20060101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>A61K   9/00        20060101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>A61K  31/375       20060101ALI20150805BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>A61K  31/70        20060101ALI20150805BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>VERFAHREN ZUR BEHANDLUNG VON LUNGENERKRANKUNGEN MIT LIPOSOMALEN AMIKACINFORMULIERUNGEN</B542><B541>en</B541><B542>METHODS OF TREATING PULMONARY DISORDERS WITH LIPOSOMAL AMIKACIN FORMULATIONS</B542><B541>fr</B541><B542>PROCÉDÉS DE TRAITEMENT DE TROUBLES PULMONAIRES PAR DES FORMULATIONS LIPOSOMALES D'AMIKACINE</B542></B540><B560><B561><text>US-A1- 2008 131 497</text></B561><B562><text>MEERS P ET AL: "Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, OXFORD UNIVERSITY PRESS, GB, vol. 61, no. 4, 1 April 2008 (2008-04-01), pages 859-868, XP002632705, ISSN: 0305-7453, DOI: 10.1093/JAC/DKN059 [retrieved on 2008-02-27]</text></B562><B562><text>RAMSEY B W ET AL: "INTERMITTENT ADMINISTRATION OF INHALED TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 340, no. 1, 7 January 1999 (1999-01-07), pages 23-30, XP001106341, ISSN: 0028-4793, DOI: 10.1056/NEJM199901073400104</text></B562><B562><text>CLANCY J P ET AL: "Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection.", THORAX SEP 2013, vol. 68, no. 9, September 2013 (2013-09), pages 818-825, XP002742980, ISSN: 1468-3296</text></B562><B565EP><date>20150812</date></B565EP></B560></B500><B700><B720><B721><snm>GUPTA, Renu</snm><adr><str>412 Salem Crossings Road</str><city>Moorestown, NJ 08057</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Insmed Incorporated</snm><iid>101845980</iid><irf>O14113.00073</irf><adr><str>700 US Highway 202/206</str><city>Bridgewater, NJ 08807-1704</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>CMS Cameron McKenna Nabarro 
Olswang LLP</snm><iid>101670164</iid><adr><str>Cannon Place 
78 Cannon Street</str><city>London EC4N 6AF</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2009060468</anum></dnum><date>20091013</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2010045209</pnum></dnum><date>20100422</date><bnum>201016</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
